| |
| |
|
| Insider
Information: |
Sherwin Stephen A |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
186,106 |
|
|
Indirect Shares
|
2,500 |
|
|
| Direct
Value |
$14,099,290 |
|
|
|
Indirect Value
|
$23,450 |
|
|
| Total
Shares |
188,606 |
|
|
| Total
Value |
$14,122,740 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neurocrine Biosciences Inc |
NBIX |
Director |
2023-11-16 |
22,305 |
2004-09-22 |
0 |
Premium* |
|
|
ANI Pharmaceuticals Inc |
ANIP |
Director |
2009-10-14 |
86,760 |
2009-10-14 |
0 |
Premium* |
|
|
Biogen Idec Inc |
BIIB |
Director |
2023-06-26 |
18,738 |
2010-03-22 |
0 |
Premium* |
|
|
Fresh Tracks Therapeutics Ord Shs |
FRTX |
Director |
2015-05-21 |
22,003 |
2013-05-23 |
0 |
Premium* |
|
|
Verastem, Inc. |
VSTM |
Director |
2014-12-26 |
0 |
2014-12-26 |
2,500 |
Premium* |
|
|
Chinook Therapeutics Inc |
KDNY |
Director |
2015-06-25 |
36,300 |
|
0 |
Premium* |
|
|
Neon Therapeutics, Inc. |
NTGN |
Director |
2020-05-06 |
0 |
2020-05-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2023-11-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,750 |
22,305 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2023-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
960 |
18,738 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2023-01-03 |
4 |
AS |
$118.85 |
$3,565,728 |
D/D |
(30,000) |
25,055 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2023-01-03 |
4 |
OE |
$12.71 |
$385,350 |
D/D |
30,000 |
40,055 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2022-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,370 |
18,473 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2022-01-24 |
4 |
AS |
$74.43 |
$1,116,378 |
D/D |
(15,000) |
25,055 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2022-01-24 |
4 |
OE |
$6.66 |
$99,900 |
D/D |
15,000 |
40,055 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2021-12-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,000 |
25,055 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2021-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
775 |
17,103 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2020-12-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,806 |
27,055 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2020-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
890 |
16,328 |
0 |
- |
|
| NTGN |
Neon Therapeutics, Inc. |
Director |
– • – |
2020-05-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(45,000) |
0 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2020-04-28 |
4 |
AS |
$99.39 |
$1,757,966 |
D/D |
(17,687) |
29,861 |
0 |
% |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2020-03-11 |
4 |
AS |
$295.22 |
$718,574 |
D/D |
(2,434) |
15,438 |
0 |
% |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2020-03-11 |
4 |
OE |
$58.46 |
$717,772 |
D/D |
12,278 |
15,708 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2019-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,155 |
6,319 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2018-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
880 |
6,014 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2018-06-11 |
4 |
AS |
$98.44 |
$984,420 |
D/D |
(10,000) |
47,548 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2018-04-26 |
4 |
OE |
$7.05 |
$105,750 |
D/D |
15,000 |
58,879 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2018-04-26 |
4 |
D |
$79.44 |
$105,735 |
D/D |
(1,331) |
57,548 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2017-11-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
850 |
5,134 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2017-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,055 |
5,984 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2017-02-07 |
4 |
D |
$43.60 |
$50,968 |
D/D |
(1,169) |
43,879 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2017-02-07 |
4 |
OE |
$3.40 |
$51,000 |
D/D |
15,000 |
45,048 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2016-11-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
4,905 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
